As of 14 Oct 2026, OmicsBank has raised $2.3M across 1 verified round on record; latest: $2.25 million seed round, announced 25 Aug 2026.
OmicsBank provides clinical data infrastructure that connects fragmented hospital data to enable drug development and healthcare AI.
omicsbank.comUnited StatesBiotechFounded 20256 employees (as of October 4, 2026)
4 sources
Orbit Ventures is mentioned as having led OmicsBank’s 2025 pre-seed round, so it is excluded from this round’s syndicate.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Seed [ REPORTED LATER ]: This round was announced before Fireround first saw it. It stays in the company's history, not in Latest, Trending, or alerts. | $2.3M | 2026-08-25 | not stated | No recent discussion |
4 sources [ VERIFIED · CORRECTED ] read against 1 of 4 sources
Orbit Ventures is mentioned as having led OmicsBank’s 2025 pre-seed round, so it is excluded from this round’s syndicate. | ||||
OmicsBank builds on-premise clinical data infrastructure that turns fragmented hospital records, imaging, pathology and omics into linked, AI-ready datasets for pharma, biotech, real-world-evidence and CRO teams, hospitals, and frontier AI labs.
Hospital data is fragmented across EHRs, labs, imaging and pathology, while South Asian populations are underrepresented in global genomic research, limiting drug development and healthcare AI. OmicsBank says its infrastructure is inside more than 90 hospitals and diagnostic labs with 12.5 million patient EHRs, more than 30 million images, 6 million pathology slides and 500,000 genome sequences, and its $2.25 million Redesign Health-led seed is funding expansion across the U.S., Middle East and Southeast Asia.
Also named as backers in company research: Orbit Ventures, NVIDIA Inception